Cargando…

ADP/ATP translocase 1 protects against an α-synuclein-associated neuronal cell damage in Parkinson’s disease model

BACKGROUND: ADP/ATP translocase 1 (ANT1) is involved in the exchange of cytosolic ADP and mitochondrial ATP, and its defection plays an important role in mitochondrial pathogenesis. To reveal an etiological implication of ANT1 for Parkinson’s disease (PD), a neurodegenerative disorder, a mouse model...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Wenyong, Qi, Minghua, Ma, Li, Xu, Xuefei, Chen, Yingfei, Zhang, Wenli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272299/ https://www.ncbi.nlm.nih.gov/pubmed/34246309 http://dx.doi.org/10.1186/s13578-021-00645-x

Ejemplares similares

The ATP/ADP translocase drives mitophagy independent of nucleotide exchange
por: Hoshino, Atsushi, et al.
Publicado: (2019)

Legionella pneumophila modulates host energy metabolism by ADP-ribosylation of ADP/ATP translocases
por: Fu, Jiaqi, et al.
Publicado: (2022)

Reversible modification of mitochondrial ADP/ATP translocases by paired Legionella effector proteins
por: Kubori, Tomoko, et al.
Publicado: (2022)

A Fluorescence-Based Method to Measure ADP/ATP Exchange of Recombinant Adenine Nucleotide Translocase in Liposomes
por: Kreiter, Jürgen, et al.
Publicado: (2020)

BMP5/7 protect dopaminergic neurons in an α-synuclein mouse model of Parkinson’s disease
por: Vitic, Zagorka, et al.
Publicado: (2020)

α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson’s disease
por: Ludtmann, Marthe H. R., et al.
Publicado: (2018)

Poly (ADP-Ribose) and α–synuclein extracellular vesicles in patients with Parkinson disease: A possible biomarker of disease severity
por: Lucien, Fabrice, et al.
Publicado: (2022)

Inflammasome inhibition protects dopaminergic neurons from α-synuclein pathology in a model of progressive Parkinson’s disease
por: Grotemeyer, Alexander, et al.
Publicado: (2023)

ATP13A2 Declines Zinc-Induced Accumulation of α-Synuclein in a Parkinson’s Disease Model
por: Gao, Huiling, et al.
Publicado: (2022)

The Roles of ATP13A2 Gene Mutations Leading to Abnormal Aggregation of α-Synuclein in Parkinson’s Disease
por: Zhang, Fan, et al.
Publicado: (2022)

α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism
por: Rodríguez-Leyva, Ildefonso, et al.
Publicado: (2014)

NXP031 prevents dopaminergic neuronal loss and oxidative damage in the AAV-WT-α-synuclein mouse model of Parkinson’s disease
por: Song, Min Kyung, et al.
Publicado: (2022)

Poly (ADP-ribose) Interacts With Phosphorylated α-Synuclein in Post Mortem PD Samples
por: Puentes, Laura N., et al.
Publicado: (2021)

Mitochondrial damage by α-synuclein causes cell death in human dopaminergic neurons
por: Ganjam, Goutham K., et al.
Publicado: (2019)

n-Butylidenephthalide Protects against Dopaminergic Neuron Degeneration and α-Synuclein Accumulation in Caenorhabditis elegans Models of Parkinson's Disease
por: Fu, Ru-Huei, et al.
Publicado: (2014)

Pharmacologic inhibition of NLRP3 reduces the levels of α-synuclein and protects dopaminergic neurons in a model of Parkinson’s disease
por: Amo-Aparicio, Jesus, et al.
Publicado: (2023)

Molecular Mechanics of RNA Translocases
por: Ding, Steve C., et al.
Publicado: (2012)

Poly (ADP‐ribose) polymerase 1 inhibition prevents neurodegeneration and promotes α‐synuclein degradation via transcription factor EB‐dependent autophagy in mutant α‐synucleinA53T model of Parkinson's disease
por: Mao, Kanmin, et al.
Publicado: (2020)

Role of cytochrome c in α-synuclein radical formation: implications of α-synuclein in neuronal death in Maneb- and paraquat-induced model of Parkinson’s disease
por: Kumar, Ashutosh, et al.
Publicado: (2016)

Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys
por: Alarcón-Arís, Diana, et al.
Publicado: (2020)

Role of microtubule-associated protein 6 glycosylated with Gal-(β-1,3)-GalNAc in Parkinson's disease
por: Ma, Li, et al.
Publicado: (2019)

Parkinson’s disease risk genes act in glia to control neuronal α-synuclein toxicity
por: Olsen, Abby L, et al.
Publicado: (2021)

The roles of connectivity and neuronal phenotype in determining the pattern of α-synuclein pathology in Parkinson's disease
por: Henderson, Michael X., et al.
Publicado: (2022)

Pathogenesis of α-Synuclein in Parkinson’s Disease: From a Neuron-Glia Crosstalk Perspective
por: Yi, Shuanglong, et al.
Publicado: (2022)

Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson’s disease patients
por: Kang, Wenyan, et al.
Publicado: (2016)

The dynamic interplay between ATP/ADP levels and autophagy sustain neuronal migration in vivo
por: Bressan, Cedric, et al.
Publicado: (2020)

α - synuclein and Parkinson’s disease: the first roadblock
por: Lin Chua, Christelle En, et al.
Publicado: (2006)

Immunological features of α-synuclein in Parkinson's disease
por: Roodveldt, Cintia, et al.
Publicado: (2008)

Models of α-synuclein aggregation in Parkinson’s disease
por: Giráldez-Pérez, Rosa María, et al.
Publicado: (2014)

Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
por: Emamzadeh, Fatemeh Nouri
Publicado: (2017)

The Role of α-Synuclein Oligomers in Parkinson’s Disease
por: Du, Xiao-yu, et al.
Publicado: (2020)

Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
por: Du, Tingting, et al.
Publicado: (2021)

α-Synuclein and neuronal cell death
por: Cookson, Mark R
Publicado: (2009)

α-Synuclein and Neuronal Cell Death
por: Yasuda, Toru, et al.
Publicado: (2012)

Systemic α-synuclein injection triggers selective neuronal pathology as seen in patients with Parkinson’s disease
por: Kuan, Wei-Li, et al.
Publicado: (2019)

DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson’s disease
por: Masato, Anna, et al.
Publicado: (2023)

Dyrk1a Phosphorylation of α-Synuclein Mediating Apoptosis of Dopaminergic Neurons in Parkinson's Disease
por: Yong, Yuxuan, et al.
Publicado: (2023)

Synuclein Family Members Prevent Membrane Damage by Counteracting α-Synuclein Aggregation
por: Scheibe, Christian, et al.
Publicado: (2021)

α-Synuclein and Anti-α-Synuclein Antibodies in Parkinson’s Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls
por: Smith, Lynnae M., et al.
Publicado: (2012)

Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity
por: Brekk, Oeystein R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_omduvp350to2t83d9psqevglae